GSK
777 hedge funds and large institutions have $10.8B invested in GSK in 2018 Q1 according to their latest regulatory filings, with 100 funds opening new positions, 290 increasing their positions, 251 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 762 → 777 (+15)
0.04% more ownership
Funds ownership: 4.4% → 4.45% (+0.04%)
21% less call options, than puts
Call options by funds: $133M | Put options by funds: $168M
Holders
777
Holding in Top 10
15
Calls
$133M
Puts
$168M
Top Buyers
| 1 | +$239M | |
| 2 | +$175M | |
| 3 | +$42.9M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$42.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$38.2M |
Top Sellers
| 1 | -$166M | |
| 2 | -$110M | |
| 3 | -$74.6M | |
| 4 |
Renaissance Technologies
New York
|
-$60.8M |
| 5 |
Two Sigma Investments
New York
|
-$59.2M |